Mike effectively lowered his A1Ca and lost some weight, while Tom lowered his A1Ca, lost weight, and reduced his risk of major cardiovascular events such as heart attack, stroke, or death
Usual Adult Dose for Heart Failure with Reduced Ejection Fraction: Dose: 10 mg orally once a day Use: Reduce the risk of cardiovascular death and hospitalization in patients with heart failure Usual Jardiance Dose for adults with chronic kidney disease that is at risk of progression
GLP-1 receptor agonists, including semaglutide, reduce alcohol intake and relapse-like behaviors in rodent and non-human primate models, and a recent clinical trial found that semaglutide decreased alcohol craving and drinking in adults with AUD
In the past ten years, a series of Phase III trials showed that the synthetic GLP-1/GIP agonists are effective in lowering blood sugar in type 2 diabetic subjects who were both treatment-nave or on typical first-line therapies such as metformin and insulin